[Viscometric study of secretolytically and mucolytically active inhalants].
Hypercrinism, dyscrinism and mucostasis are the principal symptoms accompanying diseases of the respiratory system. Both the viscosity and the adhesion of the secretion are affected by secretolytics and mucolytics. Evidence on changes in the quality of the secretion was obtained following a nine-day inhalation therapy using mucosolvin, tacholiquin, bromhexin and physiological NaCl-solution, a new viscosimetric measuring device with non-Newton liquids being applied in the investigation. The device allows for a control of the secretolytic and mucolytic treatment used.
D000336:Aerosols; D003371:Cough / Q000188:drug therapy*; D005100:Expectorants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D013183:Sputum / Q000187:drug effects*; D014783:Viscosity
D000336:Aerosols; D005100:Expectorants
Viskosimetrische Untersuchung sekretolytisch und mukolytisch wirksamer Inhalate.